RESULTS	Patients who were randomized to stepped care were more likely to report substantial bother caused by side effects ( 30 % vs 16 % for lovastatin ; P < .001 ) and discontinuation of therapy at 1 year ( 28 % vs 18 % , respectively ; P < .01 ) .\